Merit Medical Systems Other Current Assets 2010-2024 | MMSI

Merit Medical Systems other current assets from 2010 to 2024. Other current assets can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • Merit Medical Systems other current assets for the quarter ending June 30, 2024 were $M, a NAN% increase year-over-year.
  • Merit Medical Systems other current assets for 2023 were $0B, a NAN% decline from 2022.
  • Merit Medical Systems other current assets for 2022 were $0B, a NAN% decline from 2021.
  • Merit Medical Systems other current assets for 2021 were $0B, a NAN% decline from 2020.
Merit Medical Systems Annual Other Current Assets
(Millions of US $)
2023 $
2022 $
2021 $
2020 $
2019 $
2018 $
2017 $
2016 $
2015 $
2014 $
2013 $
2012 $
2011 $
2010 $
2009 $
Merit Medical Systems Quarterly Other Current Assets
(Millions of US $)
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $5.834B $1.257B
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $67.818B 18.37
McKesson (MCK) United States $65.897B 18.13
Cardinal Health (CAH) United States $26.800B 14.83
West Pharmaceutical Services (WST) United States $22.575B 44.02
Cooper (COO) United States $22.126B 31.50
Align Technology (ALGN) United States $19.210B 37.11
Labcorp (LH) United States $18.857B 15.71
Henry Schein (HSIC) United States $9.191B 16.83
DENTSPLY SIRONA (XRAY) United States $5.453B 14.62
CONMED (CNMD) United States $2.323B 20.20
Patterson (PDCO) United States $1.962B 10.35
STAAR Surgical (STAA) United States $1.554B 70.22
Lifevantage (LFVN) United States $0.129B 17.76
Pro-Dex (PDEX) United States $0.093B 44.55